A phase 1, first-in-human, multicentre, open-label, dose-escalation study of 225Ac-FPI-2068 in adult patients with advanced solid tumours

Disease:

Study phase:

Physician name:

Jordi Rodon Ahnert

Department:

Investigational Cancer Therapeutics

For general questions about clinical trials:

1-877-632-6789